Menu
GeneBe

HLA-A

major histocompatibility complex, class I, A, the group of Histocompatibility complex|C1-set domain containing

Basic information

Region (hg38): 6:29941259-29949572

Links

ENSG00000206503NCBI:3105OMIM:142800HGNC:4931Uniprot:P04439AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Drug-induced toxicity, susceptibility toADPharmacogenomicSusceptibility to adverse reactions (including Stevens-Johnson syndrome), may have pharmacogenomic relevance related to a number of medications, including allopurinol, carbamazepine; HIV disease, progression inGeneral15743917; 17258541; 21149285; 21428768; 21428769

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HLA-A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HLA-A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
0
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
2
non coding
0
Total 0 0 0 1 0

Variants in HLA-A

This is a list of pathogenic ClinVar variants found in the HLA-A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-29941373-A-G Uncertain significance (-)1049087
6-29942594-C-T - no classification for the single variant (-)1727031
6-29942772-G-A EBV-positive nodal T- and NK-cell lymphoma Likely benign (-)2681310
6-29942863-C-T - no classification for the single variant (-)1727042
6-29942944-G-A Likely benign (Jan 01, 2024)2656328
6-29942965-G-C - no classification for the single variant (-)1727050
6-29942982-T-A - no classification for the single variant (-)1727051
6-29942984-G-A - no classification for the single variant (-)1727052
6-29942985-A-G - no classification for the single variant (-)1727010
6-29942990-G-C - no classification for the single variant (-)1727011
6-29942994-C-T - no classification for the single variant (-)1727012
6-29942996-C-G - no classification for the single variant (-)1727013
6-29942997-T-C - no classification for the single variant (-)1727014
6-29943000-G-T - no classification for the single variant (-)1727015
6-29943002-G-C - no classification for the single variant (-)1727016
6-29943261-G-A Likely benign (Jul 01, 2022)2656329
6-29943287-A-G - no classification for the single variant (-)1727017
6-29943307-G-A Abnormality of neuronal migration Benign (Oct 31, 2014)208938
6-29943309-T-C - no classification for the single variant (-)1727018
6-29943321-T-C - no classification for the single variant (-)1727019
6-29943337-G-A - no classification for the single variant (-)1727020
6-29943372-C-T - no classification for the single variant (-)1727021
6-29943426-A-C - no classification for the single variant (-)1727022
6-29943448-A-G - no classification for the single variant (-)1727023
6-29943451-A-T - no classification for the single variant (-)1727024

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HLA-Aprotein_codingprotein_codingENST00000396634 84625
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001330.992808415909389931257430.198
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.09622142101.020.00001102195
Missense in Polyphen6794.2310.711021059
Synonymous0.6187986.30.9150.00000483674
Loss of Function2.36819.10.4188.27e-7199

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.4660.393
Ashkenazi Jewish0.2230.194
East Asian0.5100.444
Finnish0.1580.132
European (Non-Finnish)0.1930.154
Middle Eastern0.5100.444
South Asian0.3420.307
Other0.2400.202

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the presentation of foreign antigens to the immune system.;
Pathway
Antigen processing and presentation - Homo sapiens (human);Cell adhesion molecules (CAMs) - Homo sapiens (human);Type I diabetes mellitus - Homo sapiens (human);Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human);Allograft rejection - Homo sapiens (human);Graft-versus-host disease - Homo sapiens (human);Viral myocarditis - Homo sapiens (human);Endocytosis - Homo sapiens (human);Autoimmune thyroid disease - Homo sapiens (human);Phagosome - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Viral carcinogenesis - Homo sapiens (human);Cellular senescence - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);Proteasome Degradation;Allograft Rejection;Neutrophil degranulation;Disease;ras-independent pathway in nk cell-mediated cytotoxicity;antigen processing and presentation;Cytokine Signaling in Immune system;Host Interactions of HIV factors;HIV Infection;Post-translational protein modification;Metabolism of proteins;Infectious disease;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System;Endosomal/Vacuolar pathway;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Nef mediated downregulation of MHC class I complex cell surface expression;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Interferon gamma signaling;Protein ubiquitination;Interferon alpha/beta signaling;Antigen Presentation: Folding, assembly and peptide loading of class I MHC;Downstream signaling in naïve CD8+ T cells;Interferon Signaling;AP-1 transcription factor network;TCR signaling in naïve CD8+ T cells;E3 ubiquitin ligases ubiquitinate target proteins;IL12-mediated signaling events (Consensus)

Intolerance Scores

loftool
0.944
rvis_EVS
8.93
rvis_percentile_EVS
99.96

Haploinsufficiency Scores

pHI
0.191
hipred
N
hipred_score
0.466
ghis
0.527

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.657

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
H2-Q7
Phenotype

Gene ontology

Biological process
positive regulation of T cell mediated cytotoxicity;antigen processing and presentation of peptide antigen via MHC class I;antigen processing and presentation of endogenous peptide antigen via MHC class Ib;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent;immune response;regulation of immune response;interferon-gamma-mediated signaling pathway;type I interferon signaling pathway
Cellular component
Golgi membrane;extracellular space;endoplasmic reticulum;Golgi apparatus;plasma membrane;external side of plasma membrane;cell surface;ER to Golgi transport vesicle membrane;phagocytic vesicle membrane;early endosome membrane;MHC class I protein complex;recycling endosome membrane;integral component of lumenal side of endoplasmic reticulum membrane
Molecular function
RNA binding;signaling receptor binding;protein binding;beta-2-microglobulin binding;peptide antigen binding